跳至主要内容
临床试验/ITMCTR2200006446
ITMCTR2200006446尚未招募1 期

Clinical study on the effect of Yiqi Shengjin powder on blood pressure in patients with abnormal glucose metabolism and hypertension

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
Male

入选标准

  • 1) The subject or responsible guardian shall sign the informed consent; 2) Aged 18-75 years; 3) In patients with impaired fasting glucose, abnormal glucose tolerance or type 2 diabetes mellitus(HbA1C<8% in the past 2 weeks without taking or taking western antidiabetic drugs); 4) Patients with grade 1-2 essential hypertension; 5) TCM syndromes accord with Qi and Yin deficiency syndrome

排除标准

  • 1) Pregnant and lactation patients;
  • 2) Malignant tumors or blood diseases;
  • 3) Patients who are critically ill or not yet stable in the acute phase, have consciousness disorders, severe cognitive dysfunction or serious mental diseases;
  • 4) A history of alcohol and drug abuse;
  • 5) Patients with acute myocardial infarction, unstable angina pectoris, large aneurysm or dissecting aneurysm, NYHA class III-IV heart failure, malignant arrhythmia, and other severe liver, kidney, hematologic, cerebrovascular diseases and severe osteoporosis within 6 months (Note: Liver dysfunction is to point to alanine aminotransferase or aspartate aminotransferase value is greater than 2 times the upper limit of normal; Renal insufficiency refers to a serum creatinine value greater than 2 times the upper limit of normal);

研究者

发起方
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

相似试验